Author details

Full Name

Shixia Wang

Affiliation

ORCID

Career Start Year

1998

Papers

119

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37793559	Liposome-based peptide vaccines to elicit immune responses against the membrane active domains of the HIV-1 Env glycoprotein.		2024
37886518	Human CD4-Binding Site Antibody Elicited by Polyvalent DNA Prime-Protein Boost Vaccine Neutralizes Cross-Clade Tier-2-HIV Strains.		2023
35140230	Broadly binding and functional antibodies and persisting memory B cells elicited by HIV vaccine PDPHV.	npj Vaccines	2022
35723969	High Neutralizing Antibody Levels Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron BA.1 and BA.2 After UB-612 Vaccine Booster.	Journal of Infectious Diseases	2022
34986207	Non-neutralizing antibodies targeting the immunogenic regions of HIV-1 envelope reduce mucosal infection and virus burden in humanized mice.	PLoS Pathogens	2022
33555988	A novel DNA and protein combination COVID-19 vaccine formulation provides full protection against SARS-CoV-2 in rhesus macaques.	Emerging Microbes and Infections	2021
33853515	DNA priming immunization is more effective than recombinant protein vaccine in eliciting antigen-specific B cell responses.	Emerging Microbes and Infections	2021
33121387	The values and limitations of mathematical modelling to COVID-19 in the world: a follow up report.	Emerging Microbes and Infections	2020
31941770	Glycan Profiles of gp120 Protein Vaccines from Four Major HIV-1 Subtypes Produced from Different Host Cell Lines under Non-GMP or GMP Conditions.	J Virol	2020
32338150	Mathematic modeling of COVID-19 in the United States.	Emerging Microbes and Infections	2020
31270317	Author Correction: The wide utility of rabbits as models of human diseases.	Experimental and Molecular Medicine	2019
29789565	The wide utility of rabbits as models of human diseases.	Experimental and Molecular Medicine	2018
30027758	Using DNA Immunization to Elicit Monoclonal Antibodies in Mice, Rabbits, and Humans.	Human Gene Therapy	2018
30153309	Select gp120 V2 domain specific antibodies derived from HIV and SIV infection and vaccination inhibit gp120 binding to Î±4Î²7.	PLoS Pathog	2018
29997214	Structural Comparison of Human Anti-HIV-1 gp120 V3 Monoclonal Antibodies of the Same Gene Usage Induced by Vaccination and Chronic Infection.	Journal of Virology	2018
29449582	Use of ELISpot assay to study HBs-specific B cell responses in vaccinated and HBV infected humans.	Emerging Microbes and Infections	2018
29118121	HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded.	J Virol	2018
29498807	Application of area scaling analysis to identify natural killer cell and monocyte involvement in the GranToxiLux antibody dependent cell-mediated cytotoxicity assay.	Cytometry. Part A : the journal of the International Society for Analytical Cytology	2018
28102671	Structural Analysis of the Glycosylated Intact HIV-1 gp120-b12 Antibody Complex Using Hydroxyl Radical Protein Footprinting.	Biochemistry	2017
28933684	Screening of primary gp120 immunogens to formulate the next generation polyvalent DNA prime-protein boost HIV-1 vaccines.	Human Vaccines and Immunotherapeutics	2017
29049006	The dynamics of immunoglobulin V-gene usage and clonotype expansion in mice after prime and boost immunizations as analyzed by NGS.	Human Vaccines and Immunotherapeutics	2017
28185743	Differential induction of anti-V3 crown antibodies with cradle- and ladle-binding modes in response to HIV-1 envelope vaccination.	Vaccine	2017
27630232	Fc Receptor-Mediated Activities of Env-Specific Human Monoclonal Antibodies Generated from Volunteers Receiving the DNA Prime-Protein Boost HIV Vaccine DP6-001.	Journal of Virology	2016
26887860	Follicular regulatory TÂ cells repress cytokine production by follicular helper TÂ cells and optimize IgG responses in mice.	European Journal of Immunology	2016
27048742	DNA immunization as a technology platform for monoclonal antibody induction.	Emerging Microbes and Infections	2016
26555265	Identification of QS-21 as an Inflammasome-activating Molecular Component of Saponin Adjuvants.	Journal of Biological Chemistry	2016
26590319	A cGAS-Independent STING/IRF7 Pathway Mediates the Immunogenicity of DNA Vaccines.	Journal of Immunology	2016
27707920	Rationally Designed Immunogens Targeting HIV-1 gp120 V1V2 Induce Distinct Conformation-Specific Antibody Responses in Rabbits.	Journal of Virology	2016
27630234	Rationally Designed Vaccines Targeting the V2 Region of HIV-1 gp120 Induce a Focused, Cross-Clade-Reactive, Biologically Functional Antibody Response.	Journal of Virology	2016
26062906	N-Linked Glycosylation at an Appropriate Position in the Pre-S2 Domain Is Critical for Cellular and Humoral Immunity against Middle HBV Surface Antigen.	Tohoku Journal of Experimental Medicine	2015
25488991	Identification of Aim2 as a sensor for DNA vaccines.	Journal of Immunology	2015
26313239	Effect of vaccine administration modality on immunogenicity and efficacy.	Expert Review of Vaccines	2015
26251831	Structural analysis of a novel rabbit monoclonal antibody R53 targeting an epitope in HIV-1 gp120 C4 region critical for receptor and co-receptor binding.	Emerging Microbes and Infections	2015
25003343	Profiles of acute cytokine and antibody responses in patients infected with avian influenza A H7N9.	PLoS ONE	2014
25424808	The role of follicular helper T cells and the germinal center in HIV-1 gp120 DNA prime and gp120 protein boost vaccination.	Human Vaccines and Immunotherapeutics	2014
25424804	Optimal designs of an HA-based DNA vaccine against H7 subtype influenza viruses.	Human Vaccines and Immunotherapeutics	2014
26344472	DNA Immunization for HIV Vaccine Development.	Vaccines	2014
24335308	A novel DDB2-ATM feedback loop regulates human cytomegalovirus replication.	J Virol	2014
24658451	Concurrent measurement of dynamic changes in viral load, serum enzymes, T cell subsets, and cytokines in patients with severe fever with thrombocytopenia syndrome.	PLoS ONE	2014
24513632	Reduced MyD88 dependency of ISCOMATRIXâ¿¢ adjuvant in a DNA prime-protein boost HIV vaccine.	Human Vaccines and Immunotherapeutics	2014
25045827	Vaccine focusing to cross-subtype HIV-1 gp120 variable loop epitopes.	Vaccine	2014
25045815	Contribution of TLR4 and MyD88 for adjuvant monophosphoryl lipid A (MPLA) activity in a DNA prime-protein boost HIV-1 vaccine.	Vaccine	2014
24510291	DNA immunization.	Current Protocols in Microbiology	2013
26344467	Pilot Study on the Use of DNA Priming Immunization to Enhance Y. pestis LcrV-Specific B Cell Responses Elicited by a Recombinant LcrV Protein Vaccine.	Vaccines	2013
23864637	Rabbit anti-HIV-1 monoclonal antibodies raised by immunization can mimic the antigen-binding modes of antibodies derived from HIV-1-infected humans.	Journal of Virology	2013
23864612	A novel rabbit monoclonal antibody platform to dissect the diverse repertoire of antibody epitopes for HIV-1 Env immunogen design.	Journal of Virology	2013
23941868	Post-translational intracellular trafficking determines the type of immune response elicited by DNA vaccines expressing Gag antigen of Human Immunodeficiency Virus Type 1 (HIV-1).	Human Vaccines and Immunotherapeutics	2013
23851482	Potent monoclonal antibodies against Clostridium difficile toxin A elicited by DNA immunization.	Hum Vaccin Immunother	2013
24019983	Serum cytokine profiles associated with specific adjuvants used in a DNA prime-protein boost vaccination strategy.	PLoS ONE	2013
23884239	Cross reactivity of serum antibody responses elicited by DNA vaccines expressing HA antigens from H1N1 subtype influenza vaccines in the past 30 years.	Human Vaccines and Immunotherapeutics	2013